29 managers (29 13F filers) reported a position in NHIV shares at 2026-06-30, 10,305,760 shares in all. 29 filers opened a position and 0 filers sold out during the quarter.
Managers
29
13F filers
29
New
29
Added
0
Reduced
0
Sold out
0
Shares held by filers
10,305,760
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
No Form 4 transaction on this security in the data.
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Linden Capital L.P. and 3 other reporting persons reported 1,284,999 NHIV shares, 6.2% of the class, as of 2026-09-23, in a 13G filed 2026-09-28. 0001193125-26-404422